Zentalis closes $92.6M public offering of common stock Aug 17, 2026 04:01PM
Zentalis Pharmaceuticals Announces Closing of Underwritten Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Aug 17, 2026 04:01PM
Zentalis Pharmaceuticals prices $80.5M public stock offering Aug 13, 2026 10:23PM
Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering Aug 13, 2026 10:23PM
Zentalis Pharmaceuticals launches public stock offering Aug 13, 2026 04:01PM


Aug 13, 2026 04:01PM Zentalis Pharmaceuticals Announces Proposed Underwritten Public Offering
May 13, 2026 04:05PM Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Mar 27, 2026 12:16PM TD Cowen: Accumulate Zentalis (ZNTL) shares here
Feb 18, 2026 08:00AM Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
May 14, 2025 04:05PM Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress
Feb 24, 2025 04:05PM Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Sep 16, 2024 12:18PM TD Cowen Reiterates Buy Rating on Zentalis Pharmaceuticals (ZNTL)
May 14, 2024 07:00AM Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit
Feb 28, 2024 07:00AM Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
Jan 25, 2024 07:04AM Zentalis Pharmaceuticals (ZNTL) Announces Management Changes
Jan 25, 2024 07:00AM Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
Nov 9, 2023 07:00AM Zentalis to Participate in Investor Call Focused on Ovarian Cancer with Gynecologic Oncology Key Opinion Leader Joyce F. Liu, M.D., MPH, Hosted by TD Cowen
Jul 12, 2022 05:30AM UPDATE: Cowen Starts Zentalis Pharmaceuticals (ZNTL) at Outperform